Thursday, January 15, 2015

Regulation: The FDA is overcautious on consumer genomics Robert C Green& Nita A Farahany 15 January 2014 A US drug-agency clampdown is unwarranted without evidence of harm, say Robert C. Green and Nita A. Farahany.

No comments: